A novel human complement-related protein, C1r-like protease (C1r-LP), specifically cleaves pro-C1s

Biochemical Journal

Volumn 387, Issue 1, 2005, Pages 165-173

  Ligoudistiainou, Christina ^a   Xu, Yuanyuan ^b   Garnier, Gerard ^a   Circolo, Antonella ^a   Volanakis, John E ^a,b  

^a BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^b University of Alabama at Birmingham   (United States)

Author keywords

C1 inhibitor; C1r like protease; Classical complement pathway; Human complement related protein; Pro C1s; Serine esterase

Indexed keywords

CATALYSIS; DNA; ESTERS; GENES;

ARGININE; HUMAN GENOME; HUMAN SERUM; SERIN PROTEASES;

PROTEINS;

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ARGININE; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1R LIKE PROTEASE; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C2; COMPLEMENTARY DNA; DYFLOS; MESSENGER RNA; PEPTIDE DERIVATIVE; PROTEINASE; RECOMBINANT ENZYME; SERINE PROTEINASE; THIOESTER; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CENTROMERE; COMPLEX FORMATION; CONTROLLED STUDY; DNA ISOLATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; ENZYME STRUCTURE; EXON; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; LIVER; MOLECULAR CLONING; MOLECULAR STABILITY; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; COMPLEMENT C1; COMPLEMENT C1S; DNA, COMPLEMENTARY; HUMANS; LIVER; MOLECULAR SEQUENCE DATA; PEPTIDE HYDROLASES; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES;

EID: 17144423566     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041196     Document Type: Article

References (44)

1. Volanakis, J. E. (1998) Overview of the complement system. In The Human Complement System in Health and Disease (Volanakis, J. E. and Frank, M. M., eds.), pp. 9-32, Marcel Dekker, New York
2. Walport, M. J. (2001) Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066
3. Volanakis, J. E. (1982) Complement activation by C-reactive protein complexes. Ann. N. Y. Acad. Sci. 389, 235-250
4. Loos, M. (1982) Antibody-indepentent activation of C1, the first component of complement. Ann. Immunol. (Paris) 133, 165-179
5. Arlaud, G. J., Colomb, M. G. and Gagnon, J. (1987) A functional model of the human C1 complex. Immunol. Today 8, 106-111
6. Arlaud, G. J. and Gagnon, J. (1985) Identification of the peptide bond cleaved during activation of human C1r. FEBS Lett. 180, 234-238
7. Schumaker, V. N., Zavodszky, P. and Poon, P. H. (1987) Activation of the first component of the complement system. Annu. Rev. Immunol. 5, 21-42
8. Spycher, S. E., Nick, H. and Rickii, E. E. (1986) Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation. Eur. J. Biochem. 156, 49-57
9. Andrews, J. M. and Baillie, R. D. (1979) The enzymatic nature of the human C1r: a subcomponent of the first component of complement. J. Immunol. 123, 1403-1408
10. McRae, B. J., Lin, T. Y. and Powers, J. C. (1981) Mapping the substrate binding site of human C1r and C1s with peptide thioesters. Development of new sensitive substrates. J. Biol. Chem. 256, 12362-12366
11. Davis, III, A. E. (1988) C1 inhibitor and hereditary angioneurotic edema. Annu. Rev. Immunol. 6, 595-628
12. Wuillemin, W. A., Minnema, M., Meijers, J. C., Roem, D., Eerenberg, A. J., Nuijens, J. H., Ten Gate, H. and Hack, C. E. (1995) Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor. Blood 85, 1517-1526
13. Pixley, R. A., Schapira, M. and Colman, R. W. (1985) The regulation of human factor XIIa by plasma proteinase inhibitors. J. Biol. Chem. 260, 1723-1729
14. Schapira, M., Scott, C. F. and Colman, R. W. (1982) Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J. Clin. Invest. 69, 462-468
15. Matsushita, M., Thiel, S., Jensenius, J. C., Terai, I. and Fujita, T. (2000) Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 165, 2637-2642
16. Ziccardi, R. J. (1982) A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement. J. Immunol. 128, 2505-2508
17. Bork, P and Beckmann, G. (1993) The CUB domain. A widespread modulein developmentally regulated proteins. J. Mol. Biol. 23, 539-545
18. Journet, A. and Tosi, M. (1986) Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r. Biochem. J. 240, 783-787
19. Arlaud, G. J., Willis, A. C. and Gagnon, J. (1987) Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r. Biochem. J. 241 711-720
20. Tsai, S. W., Poon, P. H. and Schumaker, V. N. (1997) Expression and characterization of a 159 aminoacid, N-terminal fragment of human complement component C1s. Mol. Immunol. 34, 1273-1280
21. 2+-dependent interaction with C1s. J. Biol. Chem. 274, 9149-9159
22. Kardos, J., Gal, P., Szilagyi, L., Thielens, N. M., Szilagyi, K., Lorincz, Z., Kulcsar, P., Graf, L., Arlaud, G. J. and Zavodszky, P (2001) The role of the individual domains in the structure and function of the catalytic region of a modular serine protease. C1r. J. Immunol. 167, 5202-5208
23. Budayova-Spano, M., Lacroix, M., Thielens, N. M., Arlaud, G. J., Fontecilla-Camps, J. C. and Gaboriaud, C. (2002) The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J. 21, 231-239
24. Garnier, G., Circolo, A., Xu, Y. and Volanakis, J. E. (2003) Complement C1r and C1s genes are duplicated in the mouse: differential expression generates alternative isomorphs in the liver and in the male reproductive system. Biochem. J. 371, 631-640
25. Circolo, A., Garnier, G. and Volanakis, J. E. (2003) A novel murine complement-related gene encoding a C1r-like serum protein. Mol. Immunol. 39, 899-906
26. Ligoudisfianou, C., Garnier, G., Circolo, A. and Volanakis, J. E. (2002) C1r-like protein (C1r-LP): a novel human complement-related protein (Abstr. XIX Int. Complement Workshop, 22-26 September 2002, Palermo, Italy). Int. Immunopharmacol. 2. 1267-1268
27. Chirgwin, J. M., Przybyla, A. E., Mac Donald, R. J. and Rutter, W. J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299
28. Steinbuch, M. and Audran, R. (1969) The isolation of IgG from mammalian sera with the aid of caprylic acid Arch. Biochem. Biophys. 134, 279-284
29. Circolo, A., Nutter, T. B. and Strunk, R. C. (1997) Biosynthesis of complement components. In Complement: A Practical Approach (Sim, R. and Dodds, A., eds.), pp. 199-221, Oxford University Press, Oxford, U.K.
30. Kim, S., Narayana, S. V. L. and Volanakis, J. E. (1994) Mutational analysis of the substrate binding site of human complement factor D. Biochemistry 33, 14393-14399
31. Kam, C. M., McRae, B. J., Harper, J. W., Niemann, M. A., Volanakis, J. E. and Powers, J. C. (1987) Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates. J. Biol. Chem. 262, 3444-3451
32. Ponnuraj, K., Xu, Y., Macon, K., Moore, D., Volanakis, J. E. and Narayana, S. V. L. (2004) Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase. Mol. Cell 14, 17-28
33. Nakagawa, M., Yuasa, I., Irizawa, Y. and Umetsu, K. (2003) The human complement component C1R gene: fhe exon-intron structure and the molecular basis of allelic diversity. Ann. Hum. Genet. 67, 207-215
34. 2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement. Biol. Chem. 278, 32157-32164
35. Kristensen, T., D' Eustachio, P., Ogata, R. T., Chung, L. P., Reid, K. B. and Tack, B. F. (1987) The superfamily of C3b/C4b-binding proteins. Fed. Proc. 46, 2463-2469
36. Jing, H., Xu, Y., Carson, M., Moore, D., Macon, K. J. Volanakis, J. E. and Narayana, S. V. L. (2000) New structural motifs on the chymotrypsin told and their potential roles in complement factor B. EMBO J. 19, 164-173
37. Nonaka, M. and Yoshizaki, F. (2004) Evolution of the complement system. Mol. Immunol. 40, 897-902
38. Khan, A. R. and James, M. N. G. (1998) Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci. 7, 815-836
39. Patston, P. A., Gettins, P., Beechem, J. and Schapira, M. (1991) Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate. Biochemistry 30, 8876-8882
40. Fish, W. W., Orre, K. and Bjork, I. (1979) Routes of thrombin action in the production of proteolytically modified, secondary forms of antithrombin-thrombin complex. Eur. J. Biochem. 101, 39-44
41. Ziccardi, R. J. and Cooper, N. R. (1978) Modulation of the antigenicity of C1r and C1s by C1 inactivator. J. Immunol. 121, 2148-2152
42. Bagdasarian, A., Lahiri, B., Talamu, R. C., Wong, P. and Colman, R. W. (1974) Immunochemical studies of plasma kallikrein. J. Clin. Invest. 54, 1444-1454
43. Volanakis, J. E. and Narayana, S. V. L. (1996) Complement factor D: a novel serine protease. Protein Sci. 5, 553-564
44. Wicher, K. B. and Fries, E. (2004) Prohaptoglobin is proteolylically cleaved in the endoplasmic reticulum by the complement C1r-like protein. Proc. Natl. Acad. Sci. U.S.A. 101, 14390-14395